Retail sale of pharmaceutical products
MSC2 AS
Operating profit
NOK −22,000
Equity
NOK 2.0m
Incorporated
2015
Share capital
NOK 30,000
Key figures · 2025
Current ratio
0.08
Equity ratio
42.6%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -0.5% | |
| Likviditet | ||
| Current ratio | 0.08 | |
| Working capital | −2.5m | |
| Soliditet | ||
| Equity ratio (%%) | 42.6% | |
| Debt-to-equity ratio | 1.35 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.